663 related articles for article (PubMed ID: 28657871)
1. Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Brunoni AR; Moffa AH; Sampaio-Junior B; Borrione L; Moreno ML; Fernandes RA; Veronezi BP; Nogueira BS; Aparicio LVM; Razza LB; Chamorro R; Tort LC; Fraguas R; Lotufo PA; Gattaz WF; Fregni F; Benseñor IM;
N Engl J Med; 2017 Jun; 376(26):2523-2533. PubMed ID: 28657871
[TBL] [Abstract][Full Text] [Related]
2. Trial of Psilocybin versus Escitalopram for Depression.
Carhart-Harris R; Giribaldi B; Watts R; Baker-Jones M; Murphy-Beiner A; Murphy R; Martell J; Blemings A; Erritzoe D; Nutt DJ
N Engl J Med; 2021 Apr; 384(15):1402-1411. PubMed ID: 33852780
[TBL] [Abstract][Full Text] [Related]
3. The Escitalopram versus Electric Current Therapy for Treating Depression Clinical Study (ELECT-TDCS): rationale and study design of a non-inferiority, triple-arm, placebo-controlled clinical trial.
Brunoni AR; Sampaio-Junior B; Moffa AH; Borrione L; Nogueira BS; Aparício LV; Veronezi B; Moreno M; Fernandes RA; Tavares D; Bueno PV; Seibt O; Bikson M; Fraguas R; Benseñor IM
Sao Paulo Med J; 2015; 133(3):252-63. PubMed ID: 26176930
[TBL] [Abstract][Full Text] [Related]
4. The sertraline vs. electrical current therapy for treating depression clinical study: results from a factorial, randomized, controlled trial.
Brunoni AR; Valiengo L; Baccaro A; Zanão TA; de Oliveira JF; Goulart A; Boggio PS; Lotufo PA; Benseñor IM; Fregni F
JAMA Psychiatry; 2013 Apr; 70(4):383-91. PubMed ID: 23389323
[TBL] [Abstract][Full Text] [Related]
5. Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder.
Khan A; Bose A; Alexopoulos GS; Gommoll C; Li D; Gandhi C
Clin Drug Investig; 2007; 27(7):481-92. PubMed ID: 17563128
[TBL] [Abstract][Full Text] [Related]
6. Association of BDNF, HTR2A, TPH1, SLC6A4, and COMT polymorphisms with tDCS and escitalopram efficacy: ancillary analysis of a double-blind, placebo-controlled trial.
Brunoni AR; Carracedo A; Amigo OM; Pellicer AL; Talib L; Carvalho AF; Lotufo PA; Benseñor IM; Gattaz W; Cappi C
Braz J Psychiatry; 2020 Apr; 42(2):128-135. PubMed ID: 31721892
[TBL] [Abstract][Full Text] [Related]
7. Home-Use Transcranial Direct Current Stimulation for the Treatment of a Major Depressive Episode: A Randomized Clinical Trial.
Borrione L; Cavendish BA; Aparicio LVM; Luethi MS; Goerigk S; Ramos MRF; Moran NKS; Carneiro AM; Valiengo L; Moura DO; de Souza JP; Batista MP; Aparecida da Silva V; Klein I; Suen P; Gallucci-Neto J; Padberg F; Razza LB; Vanderhasselt MA; Lotufo PA; Bensenor IM; Fregni F; Brunoni AR
JAMA Psychiatry; 2024 Apr; 81(4):329-337. PubMed ID: 38170541
[TBL] [Abstract][Full Text] [Related]
8. Antidepressant effects of tDCS are associated with prefrontal gray matter volumes at baseline: Evidence from the ELECT-TDCS trial.
Bulubas L; Padberg F; Bueno PV; Duran F; Busatto G; Amaro E; Benseñor IM; Lotufo PA; Goerigk S; Gattaz W; Keeser D; Brunoni AR
Brain Stimul; 2019; 12(5):1197-1204. PubMed ID: 31105027
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Transcranial Direct Current Stimulation as an Add-on Treatment for Bipolar Depression: A Randomized Clinical Trial.
Sampaio-Junior B; Tortella G; Borrione L; Moffa AH; Machado-Vieira R; Cretaz E; Fernandes da Silva A; Fraguas R; Aparício LV; Klein I; Lafer B; Goerigk S; Benseñor IM; Lotufo PA; Gattaz WF; Brunoni AR
JAMA Psychiatry; 2018 Feb; 75(2):158-166. PubMed ID: 29282470
[TBL] [Abstract][Full Text] [Related]
10. Escitalopram for the prevention of peginterferon-α2a-associated depression in hepatitis C virus-infected patients without previous psychiatric disease: a randomized trial.
Schaefer M; Sarkar R; Knop V; Effenberger S; Friebe A; Heinze L; Spengler U; Schlaepfer T; Reimer J; Buggisch P; Ockenga J; Link R; Rentrop M; Weidenbach H; Fromm G; Lieb K; Baumert TF; Heinz A; Discher T; Neumann K; Zeuzem S; Berg T
Ann Intern Med; 2012 Jul; 157(2):94-103. PubMed ID: 22801672
[TBL] [Abstract][Full Text] [Related]
11. PsychotherapyPlus: augmentation of cognitive behavioral therapy (CBT) with prefrontal transcranial direct current stimulation (tDCS) in major depressive disorder-study design and methodology of a multicenter double-blind randomized placebo-controlled trial.
Bajbouj M; Aust S; Spies J; Herrera-Melendez AL; Mayer SV; Peters M; Plewnia C; Fallgatter AJ; Frase L; Normann C; Behler N; Wulf L; Brakemeier EL; Padberg F
Eur Arch Psychiatry Clin Neurosci; 2018 Dec; 268(8):797-808. PubMed ID: 29214483
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Tianeptine 25-50 mg in Elderly Patients With Recurrent Major Depressive Disorder: An 8-Week Placebo- and Escitalopram-Controlled Study.
Emsley R; Ahokas A; Suarez A; Marinescu D; Dóci I; Lehtmets A; Milanova V; Lee MS; Didi R; Araszkiewicz A; Sulaiman AH; Blanchot FP; Crutel VS; Antoine C; Penelaud PF
J Clin Psychiatry; 2018 Jul; 79(4):. PubMed ID: 29995359
[TBL] [Abstract][Full Text] [Related]
13. Cognitive changes after tDCS and escitalopram treatment in major depressive disorder: Results from the placebo-controlled ELECT-TDCS trial.
Moreno ML; Goerigk SA; Bertola L; Suemoto CK; Razza LB; Moffa AH; Veronezi BP; Tort L; Nogueira BS; Gattaz WF; Fraguas R; Padberg F; Lotufo PA; Benseñor IM; Brunoni AR
J Affect Disord; 2020 Feb; 263():344-352. PubMed ID: 31969264
[TBL] [Abstract][Full Text] [Related]
14. Escitalopram versus placebo in the treatment of dysthymic disorder.
Hellerstein DJ; Batchelder ST; Hyler S; Arnaout B; Toba C; Benga I; Gangure D
Int Clin Psychopharmacol; 2010 May; 25(3):143-8. PubMed ID: 21811192
[TBL] [Abstract][Full Text] [Related]
15. Escitalopram for severe asthma and major depressive disorder: a randomized, double-blind, placebo-controlled proof-of-concept study.
Brown ES; Howard C; Khan DA; Carmody TJ
Psychosomatics; 2012; 53(1):75-80. PubMed ID: 22221724
[TBL] [Abstract][Full Text] [Related]
16. Effects of transcranial direct current stimulation using miniaturized devices vs sertraline for depression in Korea: A 6 week, multicenter, randomized, double blind, active-controlled study.
Park S; Choi WJ; Kim S; Kim B; Son SJ; Roh D; Kim WJ; Park JY
J Psychiatr Res; 2020 Aug; 127():42-47. PubMed ID: 32464489
[TBL] [Abstract][Full Text] [Related]
17. Escitalopram in the treatment of adolescent depression: a randomized placebo-controlled multisite trial.
Emslie GJ; Ventura D; Korotzer A; Tourkodimitris S
J Am Acad Child Adolesc Psychiatry; 2009 Jul; 48(7):721-729. PubMed ID: 19465881
[TBL] [Abstract][Full Text] [Related]
18. Parsing the antidepressant effects of non-invasive brain stimulation and pharmacotherapy: A symptom clustering approach on ELECT-TDCS.
Goerigk SA; Padberg F; Chekroud A; Kambeitz J; Bühner M; Brunoni AR
Brain Stimul; 2021; 14(4):906-912. PubMed ID: 34048940
[TBL] [Abstract][Full Text] [Related]
19. A randomized controlled trial of the efficacy and safety of lisdexamfetamine dimesylate as augmentation therapy in adults with residual symptoms of major depressive disorder after treatment with escitalopram.
Trivedi MH; Cutler AJ; Richards C; Lasser R; Geibel BB; Gao J; Sambunaris A; Patkar AA
J Clin Psychiatry; 2013 Aug; 74(8):802-9. PubMed ID: 24021497
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
